NUTLEY, NJ — The township of Nutley hosted the “Welcome to Nutley ON3” event at Nichols Park...
Hackensack Meridian Center for Discovery and Innovation
NUTLEY, NJ — A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for...
NUTLEY, NJ — Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co. Ltd., announced Aug. 18 the...
NUTLEY, NJ — A unique collaborative enterprise of academic and pharmaceutical experts in New York City and...
NUTLEY, NJ — Prism Capital Partners and its ON3 development were honored this spring by the Urban...
NUTLEY, NJ — Hackensack Meridian Health Foundation announced the receipt of a gift of $100,000 from SUEZ...
NUTLEY, NJ — David S. Perlin, chief scientific officer and senior vice president of the Hackensack Meridian...
NUTLEY, NJ — Scientists from the Hackensack Meridian Center for Discovery and Innovation in Nutley, working with...
NUTLEY, NJ — Tiny genetic markers, circulating in the blood, have shown great promise in diagnosing and...
NUTLEY, NJ — Experts at the Hackensack Meridian Center for Discovery and Innovation in Nutley have developed...
